KCT0000396已完成未知
A Phase I, Randomized, Open, Multi-center, Cross over study to Evaluate the Therapeutic Equivalence of Repeated Dose of HCP0910 250/50 µg to SeretideTM 250 DiskusTM in Asthmatic Patients
Hanmi Pharm0 个研究点目标入组 48 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20(Year) 至 75(Year)（—）
- 性别
- All
入选标准
- •1. BDR test: after Ventolin FEV1 increase 12% and 200mL over
- •2. Before Ventolin FEV1 > 60%
排除标准
- •1. 10 pack-year smoking history
- •2. 14 units over/ a week of alcohol or drug abuse
研究者
相似试验
进行中（未招募）
不适用
Phase III Clinical Trial to Evaluate the Efficacy and Safety of DA-3002 Treatment in Children with Idiopathic Short StatureEndocrine, nutritional and metabolic diseaseKCT0000896Dong-A ST64
进行中（未招募）
不适用
Immunogenicity Study of a DTaP-IPV-Hep B-PRP-T Combined Vaccine in Comparison to CombAct-Hib™ Concomitantly Administered with Engerix B™ Paediatric and OPV at 6, 10, and 14 weeks of Age in South African InfantsPrevention of infections caused by Corynebacterium diphtheriae, Clostridium tetani, Bordetella pertussis, poliovirus types 1, 2 and 3, prevention against invasive infections caused by Haemophilus influenzae type b and infection caused by hepatitis B virusMedDRA version: 14.1Level: PTClassification code 10021430Term: ImmunisationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 14.1Level: LLTClassification code 10036897Term: Prophylactic vaccinationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 14.1Level: HLTClassification code 10021431Term: ImmunisationsSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 14.1Level: HLGTClassification code 10043413Term: Therapeutic procedures and supportive care NECSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2011-004433-14-Outside-EU/EEASanofi Pasteur SA715
进行中（未招募）
1 期
A clinical trial: treatment of adult Wilson's Disease patients with gene therapyEUCTR2020-000963-22-DEVivet Therapeutics SAS16
招募中
1 期
Treatment of adult Wilson's Disease patients with gene therapyWilson's DiseaseMedDRA version: 20.0Level: LLTClassification code: 10047988Term: Wilson's disease Class: 10010331CTIS2023-509998-23-00Vivet Therapeutics16
进行中（未招募）
1 期
A clinical trial: treatment of adult Wilson's Disease patients with gene therapyWilson's DiseaseMedDRA version: 20.0Level: LLTClassification code 10047988Term: Wilson's diseaseSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2020-000963-22-DKVivet Therapeutics SAS16